Federal regulators are taking a closer look at how caffeine is disclosed on packaged drinks as the energy beverage category continues to grow across the U.S. That broader policy push now intersects directly with Celsius and Alani Nu, two widely sold brands that have come under fresh scrutiny over labeling, marketing, and youth safety concerns. The FDA’s latest agenda does not single out those companies by name, but it arrives as both brands are central to the current debate.
FDA adds caffeine labeling to its 2026 priority list
The FDA said on June 29, 2026, that “Labeling Caffeine Content in Foods and Beverages” is part of its 2026 Human Foods Program guidance agenda, according to the agency’s published priority list. The action does not amount to a recall or enforcement order, but it signals that the agency is considering draft guidance for industry on how caffeine content should be presented on food and beverage labels. That matters for a fast-growing category in which many drinks already disclose caffeine voluntarily, while federal rules do not generally require brands to print the actual amount of caffeine on the package.
The timing is significant because Celsius Holdings and Alani Nu are already under the microscope from regulators and litigants. Food Dive reported on July 2 that the FDA disclosure came as energy drinks and other high-caffeine beverages face rising scrutiny over whether they provide adequate warnings, especially for children. Celsius became a focal point after Texas Attorney General Ken Paxton opened an investigation into the company earlier in June.
Current FDA rules require caffeine to appear in the ingredient list when it is added as a standalone ingredient, but not necessarily as a numeric amount on the label. If a product contains ingredients that naturally include caffeine, such as coffee or chocolate, consumers may see only the ingredient name rather than a caffeine total. The FDA also said its guidance agendas identify priorities, but do not guarantee that every listed guidance will be issued on a fixed timetable.
Texas is the clearest flashpoint, but the full retail impact is not yet public
Texas is the clearest confirmed state-level flashpoint in this story. On June 4, 2026, Attorney General Ken Paxton announced that his office had opened an investigation into Celsius Holdings, which owns Alani Nutrition, over whether the company marketed high-caffeine beverages to teens and children and misrepresented their safety, according to the attorney general’s office and multiple local news reports. Coverage of the probe said Alani Nu drinks cited in the investigation contain 200 milligrams of caffeine per can.
What is confirmed is the existence of the Texas investigation and its focus on youth marketing and caffeine-related risk disclosures. What is not yet known is whether any specific Texas retailers, grocery chains, convenience stores, or school-adjacent outlets will change product placement, signage, or sales practices as a result. Celsius and Alani Nu remain broadly available, and neither the FDA nor Texas officials have announced a product recall tied to this matter.
The company also has not released a comprehensive public list of Texas locations where any merchandising, warning, or promotional practices might be reviewed or changed. There is likewise no publicly confirmed state-by-state breakdown showing whether Texas faces different store-level actions than other states. For consumers, the state impact is therefore regulatory and informational at this stage, not a confirmed withdrawal from shelves.
The pressure reflects a wider debate over youth marketing, labeling gaps, and energy drink oversight
The immediate reason this is happening is the convergence of two issues: limited federal labeling specificity for caffeine and growing concern over how energy drinks are marketed to younger consumers. The FDA said in its 2026 priority materials that rising consumption of caffeinated foods and beverages is driving new attention to industry best practices. That framing suggests the agency sees a broader labeling issue, not just a dispute involving one or two brands.
At the same time, Texas officials tied their investigation to alleged safety and marketing concerns involving minors. Reports citing the attorney general’s office said the probe followed the death of a 17-year-old Alani Nu consumer, with attorneys for the family alleging excessive caffeine consumption contributed to an enlarged heart. Those allegations remain part of an active legal and regulatory dispute, but they have intensified scrutiny around how prominently high caffeine levels and related risks are disclosed.
For shoppers, the practical takeaway is that Celsius and Alani Nu are still on the market while regulators examine whether clearer caffeine labeling is needed. No recall number exists because no FDA recall has been announced in connection with this development. What customers should expect next is policy movement rather than an immediate product disappearance: the FDA has signaled that caffeine labeling guidance is now an official 2026 priority, and that places the energy drink aisle under closer federal review.